Gen­mab and BioN­Tech to col­lab­o­rate on new can­cer can­di­date; Small Aus­tralian biotech sees hope in brain metas­tases tri­al

Two Eu­ro­pean biotechs are up­ping the ante on their col­lab­o­ra­tion.

Gen­mab and BioN­Tech will ex­pand their re­la­tion­ship to de­vel­op and po­ten­tial­ly com­mer­cial­ize new im­munother­a­pies for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER